Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Psychoneuroendocrinology. 2015 Aug 28;62:327–335. doi: 10.1016/j.psyneuen.2015.08.021

Table 1.

Characteristics of Participants at MESA Exam 5 (2010–2012) *

Characteristic Non-diabetes Diabetes
Participants - n (%) 680 (80) 170 (20)
Demographic
Age - years 69.6 ± 9.3 70.1 ± 8.1
Female sex - n (%) 370 (54) 95 (56)
Male sex - n (%) 310 (46) 75 (44)
Race/Ethnicity - n (%) §
Non-Hispanic White 200 (29) 15 (9)
African-American 193 (28) 73 (43)
Hispanic 287 (42) 82 (48)
Gross family annual income (US Dollars) 50085 ± 34113 40188 ± 31524
Clinical
HbA1c – % 5.7 ± 0.4 7.2 ± 1.7
HbA1c (log-scale) – % 1.7 ± 0.1 2 ± 0.2
HOMA-IR 246.3 ± 173.2 N/A
HOMA-IR (log-scale) 5.3 ± 0.7 N/A
Fasting glucose (mg/dL) 94.2 ± 9.6 135.6 ± 54.6
Fasting Insulin (pmol/L) 57.5 ± 37.7 77.5 ± 45.3
Body-mass index 29 ± 5.4 31.7 ± 5.5
Waist circumference (cm) 99.5 ± 13.8 107.5 ± 13.4
Beta-blocker - n (%) 105 (15) 57 (34)
Steroid - n (%) 31 (5) 7 (4)
Hormone replace therapy - n (%) 18 (3) 0 (0)
Aspirin therapy - n (%) 282 (41) 103 (61)
Current Smoking - n (%) 32 (5) 14 (8)
CES-D score 8.3 ± 7.9 9.3 ± 8
Log Transformed Cortisol Features #
Wake-up Cortisol 2.59 ± 0.85 2.54 ± 0.79
Cortisol Awakening Response 0.28 ± 0.72 0.24 ± 0.75
Early Decline Slope −0.45 ± 0.52 −0.34 ± 0.49
Late Decline Slope −0.09 ± 0.07 −0.09 ± 0.07
Overall Decline Slope −0.10 ± 0.06 −0.09 ± 0.06
Bedtime Cortisol 1.10 ± 0.87 1.20 ± 0.85
Total AUC (16-hours) Cortisol 1.70 ± 0.65 1.78 ± 0.59
Diabetes Status
Normal - n (%) 503 (74)
Impaired Fasting Glucose - n (%) 177 (26)
Untreated Diabetes - n (%) 10 (6)
Treated Diabetes - n (%) 160 (94)
*

Plus-minus values are means ± SD.

§

Race was self-reported.

HOMA-IR was not calculated for participants with diabetes.

The body-mass index is the weight in kilograms divided by the square of the height in meters.

#

Cortisol features were calculated using log-transformed cortisol values (unit: log(nmol/L)); for complete analytic data see Supplemental Table 2.